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Stem cells might provide unlimited supply of transplantable cells for β-cell replacement therapy in diabetes.
The human limbus is a highly specialized region hosting a well-recognized population of epithelial stem
cells, which sustain the continuous renewal of the cornea, and the recently identified stromal fibroblast-like
stem cells (f-LSCs), with apparent broader plasticity. However, the lack of specific molecular markers for
the identification of the multipotent limbal subpopulation has so far limited the investigation of their differen-
tiation potential. In this study we show that the human limbus contains uncommitted cells that could be
potentially harnessed for the treatment of diabetes. Fourteen limbal biopsies were obtained from patients
undergoing surgery for ocular diseases not involving the conjunctiva or corneal surface. We identified a
subpopulation of f-LSCs characterized by robust proliferative capacity, expressing several pluripotent stem
cell markers and exhibiting self-renewal ability. We then demonstrated the potential of f-LSCs to differenti-
ate in vitro into functional insulin-secreting cells by developing a four-step differentiation protocol that
efficiently directed f-LSCs towards the pancreatic endocrine cell fate. The expression of specific endodermal,
pancreatic, islet, and β-cell markers, as well as functional properties of f-LSC-derived insulin-producing
cells, were evaluated during differentiation. With our stage-specific approach, up to 77% of f-LSCs eventu-
ally differentiated into cells expressing insulin (also assessed as C-peptide) and exhibited phenotypic features
of mature β-cells, such as expression of critical transcription factors and presence of secretory granules.
Although insulin content was about 160-fold lower than what observed in adult islets, differentiated cells
processed 98% of their proinsulin content, similar to mature β-cells. Moreover, they responded in vitro in
a regulated manner to multiple secretory stimuli, including glucose. In conclusion, f-LSCs represent a possi-
ble relevant source of autologous, transplantable, insulin-producing cells that could be tested for the reversal
of diabetes.
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INTRODUCTION virtually differentiate into any phenotype, might provide
an unlimited supply of surrogate β-cells. However, their
clinical application is affected by ethical and technicalType 1 diabetes is caused by the autoimmune destruc-
tion of pancreatic β-cells, which leads to their virtually challenges. Hence, adult multipotent stem cells are now
being widely evaluated. Nevertheless, the scarcity of thecomplete eradication (2). Currently available options for
β-cell replacement therapy (i.e., whole pancreas or iso- source, the invasive procedures often required to isolate
these cells, and their restricted differentiation potentiallated islet transplantation) are limited by the shortage of
organ donors and the need for life-long immunosuppres- have limited their use in translational medicine (1).
The purpose of our study was to identify a novel pop-sion (33). A variety of stem cells may be potentially
harnessed for the treatment of type 1 diabetes. Embry- ulation of uncommitted cells that could offer advantages
over the countless stem cell sources proposed so far foronic stem cells (ESCs), which are able to self-renew and
Received October 22, 2010; final acceptance March 14, 2011. Online prepub date: June 9, 2011.
Address correspondence to Carla Giordano, Sezione di Endocrinologia, Dipartimento Biomedico di Medicina Interna e Specialistica (Di.Bi.M.I.S.),
Universita` degli Studi di Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy. Tel: +39 0916552109; Fax: +39 0916552123;
E-mail: carla.giordan@unipa.it
73
74 CRISCIMANNA ET AL.
β-cell replacement therapy. The limbus is a highly were plated in cell culture-treated flasks following fine
dissection with a sterile blade. After 24–48 h, adherentspecialized region of the eye hosting a well-recognized
population of epithelial stem cells (LESCs), which con- colonies of f-LSCs and small cuboidal cells (epithelial)
were obtained. At the same time, floating spherical celltinuously renew the corneal surface (8). The limbal
niche is characterized by stromal invaginations that pro- clusters or “limbospheres” started forming. Limbospheres
progressively increased in number and size and attachedvide anatomical and functional dimensions to maintain
“stemness,” protect stem cells from traumatic and envi- to the plastic surface, eventually generating highly pro-
liferating fibroblast-like outgrowths (see Fig. S1A, avail-ronmental insults, allow epithelial–mesenchymal inter-
actions, and supply access to chemical signals that able at: https://sites.google.com/site/endocrinologycgior
dano/cell-transplantation-journal_supplemental-material).diffuse from the rich underlying vascular network (14).
A critical advantage of limbal cells is that they are easily To better select f-LSCs from epithelial cells, forming
limbospheres were transferred into new flasks. Limbalaccessible with a well-established and minimally inva-
sive procedure (13,22,35). LESCs have been widely cells were cultured in F12/DMEM medium supple-
mented with 10% embryonic stem cell-tested fetalcharacterized (4,8–10,12,14) and investigated for their
differentiation potential, which seems to be restricted, bovine serum (FBS; PAA), 1× insulin-transferrin-sele-
nium (ITS; PAA), and 4 ng/ml basic fibroblast growththe corneal fate. However, human ocular stem cell
research has been mainly focused on the tissue-specific factor (bFGF; Sigma-Aldrich) (expansion medium). Cul-
tures were maintained in 5% CO2 in a humidified incu-differentiation that may be of clinical significance in the
context of eye diseases, as demonstrated by their clinical bator at 37°C. Population doublings were calculated as
[log10 (final cell number/starting cell number)/log102].use in ocular surface reconstruction (13,22,35). There is
recent evidence that the limbal niche also hosts stromal Karyotype analysis was performed by cytogenetic stan-
dard protocol on all primary cell cultures.fibroblast-like stem cells (f-LSCs), with apparent multi-
lineage transdifferentiation potential (11,12,28). Pheno-
Flow Cytometrytype of f-LSCs is reportedly characterized by variable
expression of several stem cells markers, which are dis- Cells were treated with FcR blocking reagent
(Miltenyi Biotec) and incubated with primary antibodytinct from those described for LESCs (4,9,10). However,
the lack of agreement on specific molecular hallmarks at 4°C for 20 min. Cells were washed twice with PBS
and incubated with secondary antibodies at 4°C for 20for the identification of the pluripotent subpopulation
among the limbal stromal cells has so far limited the min in the dark. Intracellular staining was performed
using Cytofix/Cytoperm and Perm/Wash buffer (BDinvestigation of their differentiation potential to a few
studies (11,28). Pharmingen), according to the manufacturer’s instructions.
The sources of antibodies and dilutions used are summa-Here we describe a subpopulation of f-LSCs charac-
terized by robust proliferative capacity, stable expression rized in Table S1A (see supplementary material at:
https://sites.google.com/site/endocrinologycgiordano/cell-of several pluripotent stem cell markers, and self-renewal
ability. We then demonstrate that f-LSCs are able to transplantation-journal_supplemental-material). Freshly
isolated peripheral blood mononuclear cells (PBMCs)generate pancreatic endocrine cells. To this end, we have
developed a four-step differentiation protocol aimed at and HeLa cells were used as positive controls for hema-
topoietic markers and p63(∆N), respectively. Data weredirecting f-LSCs through a series of intermediates simi-
lar to those occurring during pancreatic organogenesis, acquired on a FACSCalibur and analyzed using CELL
Quest Pro software (Becton Dickinson) and are repre-efficiently leading to production of functional hormone-
expressing cells. With our stage-specific approach we sentative of at least five independent experiments.
obtained up to 77% of insulin-producing cells. More
Assessment of Self-Renewal Abilityimportantly, differentiated f-LSCs possessed the ability
to secrete C-peptide in response to glucose and other Prior to assay, cells were sorted for stage specific
embryonic antigen 4 (SSEA4) to ensure a purifiedstimuli, similar to mature β-cells.
f-LSC population. Single-cell suspension of undifferen-
MATERIALS AND METHODS tiated f-LSCs was labeled with mouse anti-human
Establishment of Limbal Cell Cultures SSEA4 antibody (Santa Cruz Biotechnology, sc-21704).
Magnetic isolation was carried out by Magnetic Acti-Two to three mm2 limbal biopsies were obtained
from 14 patients undergoing surgery for ocular diseases vated Cell Sorting (MACS) technology using goat
anti-mouse IgG microbeads (Miltenyi Biotec), accordingnot involving the conjunctiva or corneal surface. Patients
gave written informed consent and the IRB of the Uni- to the manufacturer’s instructions. After sorting, cell
purity was evaluated by flow cytometry and immunoflu-versity of Palermo approved the study according to the
tenets of the Declaration of Helsinki. Briefly, explants orescence. Sorted SSEA4+ f-LSCs were then labeled
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with CellTraceTM Carboxyfluorescein succinimidyl ester Immunofluorescence
(CFSE) Cell Proliferation Kit (Molecular Probes, Cells were differentiated in culture slides (BD Biosci-
Invitrogen), according to the manufacturer’s instruc- ences) and stained at different time points in order to
tions. Cells were then cultured either in expansion preserve the morphology of islet-like clusters. Cells
medium or in RPMI-1640 supplemented with 10% FBS were fixed for 15 min at room temperature (RT) in 2%(basal medium), fixed with 2% paraformaldehyde at 24, (w/v) paraformaldehyde, permeabilized with 0.1% PBS/
48, and 72 h, and stained for SSEA4. Images were Triton X-100 (Sigma-Aldrich), washed in PBS, and
acquired with DM IRB inverted microscope equipped blocked for 30 min in 3% PBS/BSA (bovine serum
with DC300F digital camera system. Alternatively, self- albumin). Primary antibodies were incubated for 24 h at
renewal assay was performed over a 15-day period as 4°C, while secondary antibodies were incubated for 1 h
previously described (45). Briefly, sorted SSEA4+ cells at RT. The sources of antibodies and dilutions used are
were cultured as described above and SSEA4 expression summarized in Table S1B (supplemental material).
was detected by flow cytometry on days 0, 4, 8, 12, and Images were acquired with DM IRB inverted micro-
15. At the same time points cell proliferation was scope equipped with DC300F digital camera system or
assessed by Cell Proliferation Elisa, bromodeoxyuridine TCS SP5 confocal microscope (all by Leica Microsys-(BrdU) (colorimetric) kit (Roche) according to the man- tems). All fields are representative of at least five inde-
ufacturer’s instructions. Apoptosis was assessed by pendent experiments.
Annexin V-FITC (fluorescein isothiocyanate) Apoptosis
Detection kit (BD Pharmingen) following the manufac- Western Blot Analysis
turer’s instructions. Data are representative of at least
Cells were harvested and resuspended in 200 µl offive independent experiments.
1× ice-cold NP40 lysis buffer [50 mM Tris-HCl, pH 7.6,
150 mM NaCl, 1% NP40, 1% sodium dodecyl sulfateDifferentiation Towards the Pancreatic Phenotype (SDS), 0.5% sodium deoxycholate, 2 mM NaF, 2 mM
Differentiation with protocol A was performed in sodium orthovanadate (Na3VO4)] supplemented with a
nine f-LSC cultures, and each cell culture was differenti- cocktail of protease inhibitors (CompleteTM, Roche).
ated three or more times. Protocol B was tested in paral- Proteins of human islets were obtained as previously
lel experiments in three out of nine f-LSC cultures used described (31). Electrophoresis of 3 µg (for human
for protocol A. islets) or 15 µg (for differentiated f-LSCs) lysates was
performed on polyacrylamide gels [4–20% (w/v), Bis-Protocol A. In stage 1, cells were cultured for 2–3
days in RPMI-1640 supplemented with 100 ng/ml Tris NuPage, Invitrogen]. The sources of antibodies and
dilutions used are summarized in Table S1C (supple-Activin A (Peprotech); in stage 2, cells were treated for
3–4 days with RPMI-1640 supplemented with 2% mental material). Horseradish peroxidase-conjugated
secondary antibodies (Santa Cruz Biotechnology) andembryonic stem cell-tested FBS and 50 ng/ml bFGF; in
stage 3, cells were cultured for 3–4 days with advanced chemiluminescent substrate (SuperSignal West Pico,
Pierce) were used for detection with a Bio-Rad Chemi-DMEM supplemented with 10% embryonic stem cell-
tested FBS, 1% B27 (PAA), 2% N2 (PAA), and 1 mM doc XRS Imager. Data are representative of at least five
independent experiments.nicotinamide (Sigma-Aldrich); in stage 4, cells were cul-
tured for 3–4 days in advanced DMEM supplemented
with 10% embryonic stem cell-tested FBS, 1% B27, Real-Time Quantitative PCR (qRT-PCR)
2% N2, 1 mM nicotinamide, and 50 ng/ml exendin-4 mRNA isolation and subsequent cDNA synthesis(Sigma-Aldrich). were performed using µMACS One-step cDNA Kit
(Miltenyi Biotec) according to the manufacturer’sProtocol B. In stage 1 cells were cultured as
described in protocol A; in stage 2 cells were treated instructions. PCR primers were purchased from Qiagen
(QuantiTect Primer Assays, Qiagen) and are listed infor 3–4 days with RPMI-1640 supplemented with 2%
embryonic stem cell-tested FBS (PAA) and with 50 ng/ Table S1D (supplemental material). All reactions were
performed with Quantitect Sybr Green PCR Kit (Qiagen)ml FGF10 (Sigma-Aldrich); stage 3 was carried out in
advanced DMEM supplemented with 1% B27, 50 ng/ml using a LightCycler 1.5 Instrument (Roche). Reactions
were performed at least in triplicate. Specificity of theFGF10, and 2 µM retinoic acid (RA; Sigma-Aldrich); in
stage 4 cells were cultured in advanced DMEM supple- amplified products was determined by melting peak
analysis. Quantification for each gene of interest wasmented with 1% B27 and 50 ng/ml exendin-4. All of the
data represented were generated with protocol A using performed in relation to a standard curve represented by
the appropriate cDNA plasmid. Quantified values werethe same primary cell culture, except where differ-
ently indicated. normalized against the housekeeping gene β-actin.
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cDNA of human islets was obtained from adult cadav- micrograms of total proteins. We used 500,000 differ-
entiated f-LSCs and an equal mass of islet equivalentseric donors as previously described (31).
(IEQ) (250 islets with an estimate of 2,000 cells per
Transmission Electron Microscopy IEQ) (31). Data are representative of five indepen-
dent experiments.Pellets were fixed for 20 min in 2% paraformalde-
hyde; postfixed for 15 min with 1% osmium tetroxide,
RESULTS
dehydrated through graded ethanol concentrations, and
embedded in epoxy resin (Durcupan ACM). Sections
(80 nm thick) were cut with an Ultracut-Reichert Micro-
f-LSCs Express Pluripotent Markers and Exhibittome, mounted on nickel grids, and stained with 1% ura-
Self-Renewal Abilitynyl acetate and lead citrate. Analysis was performed on
a Zeiss EM 109 electron microscope. Limbal explants were finely dissected with a sterile
blade and cells were plated in cell culture-treated flasks.
Insulin Content and C-Peptide Release Assays After 24–48 h, a few colonies of small cuboidal (epithe-
(Static Incubation) lial) cells and several colonies of f-LSCs were observed.
At the same time, the single cell suspension gave rise toAfter discarding differentiation media, cells (both
monolayer and islet-like clusters) were washed several floating spherical cell clusters, which we termed “limbo-
spheres.” Limbospheres progressively increased in num-times and then incubated for 1 h in Krebs-Ringer solu-
tion with bicarbonate and HEPES [KRBH; 129 mM ber and size and after a few days attached to the plastic
surface, eventually giving rise to highly proliferatingNaCl, 4.8 mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4,
1.2 mM MgSO4, 5 mM NaHCO3, 10 mM HEPES, 0.1% fibroblast-like outgrowths. f-LSCs soon prevailed after
1 week of culture; however, to better select f-LSCs from(w/v) BSA], followed by 1-h incubation in KRBH con-
taining 2 mM D-glucose (basal condition). Cells were epithelial cells, forming limbospheres were transferred
in new flasks. Upon replating, limbospheres exclu-then incubated for another 1 h in stimulating conditions
with 20 mM D-glucose, 100 µM tolbutamide or 30 mM sively generated f-LSCs. Cell morphology and growth
rate of f-LSCs are shown in Figure 1A and B; a sketchKCl, respectively (all from Sigma-Aldrich). Plates were
incubated at 37°C on a rotating shaker and the superna- illustrating isolation of f-LSCs from limbal explants is
shown in Figure S1A (supplemental material). Primarytant was sampled at basal conditions and at the time
points 1, 2, 3, 5, 7, 10, 15, 30, and 60 min. C-peptide f-LSC cultures were obtained from all 14 limbal biop-
sies and maintained normal karyotype (46XX or 46XY)content and release were assessed with C-peptide ELISA
Kit (Mercodia) on cell lysates or supernatants, respec- during long-term culture. Figure 1C shows a represen-
tative karyotype at P30, corresponding to 60 popula-tively. Proinsulin content was measured on cell lysates
with Proinsulin Elisa Kit (Mercodia). The fold increase tion doublings.
Immunophenotype of f-LSCs was assessed by flowwas calculated for each culture condition by dividing
the C-peptide concentration in the stimulation superna- cytometry (Fig. 1D). Freshly digested limbal specimens
(which included also epithelial cells) showed significanttant at 60 min by the C-peptide concentration in the
basal supernatant. Total insulin content was calculated expression of the pluripotent stem cell marker SSEA4
(mean ± SD: 65.2 ± 7.6%; data not shown), which hadas the sum of C-peptide (pM) and proinsulin (pM) per
FACING PAGE
Figure 1. f-LSCs express several pluripotent stem cell markers and exhibit self-renewal ability. (A) Morphology of cultured
fibroblast-like stem cells (f-LSCs). After 24–48 h in culture, the single cell suspension gives rise to floating spherical cell clusters
or “limbospheres”, which progressively increase in number and size and attach to the plastic surface (upper left). Colonies of small
cuboidal adherent cells (epithelial) are also observed (upper right); however, f-LSCs soon prevail after 1 week of culture. Upon
replating, limbospheres are able to generate only highly proliferating fibroblast-like outgrowths (lower left and lower right). Primary
cultures were obtained from all 14 limbal biopsies as indicated in the Materials and Method section. See also Figure S1A (supple-
mental material) for graphic illustration of f-LSC isolation from limbal explants. Scale bars: 400 µm. (B) Kinetics of f-LSCs in
expansion medium. Cells were counted using trypan blue exclusion dye at each passage. (C) f-LSCs maintain a normal karyotype
in long-term cultures. The figure shows a representative karyotype at P30, corresponding to 60 population doublings. (D) Fluores-
cence-activated cell sorting (FACS) analysis shows f-LSCs are positive for several nuclear and surface stem cell markers. Data are
representative of at least five independent experiments. (E) qRT-PCR confirms expression of pluripotent stem cell markers. Each
bar represents mean ± SE (log scale) of the gene of interest in all 14 primary cell cultures. Quantification for each gene of interest
was performed in relation to its own standard curve (arbitrary units) and expression was normalized for the housekeeping gene
β-actin.
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been previously proposed as a reliable marker for f- steady state up to the last day of the assay. Instead, cell
proliferation (detected by BrdU) was observed duringLSCs (11). After 10–12 population doublings in stem
cell expansion medium, or at earlier passages in primary the entire culture period. Assessment of apoptosis by
Annexin V-FITC at the same time points demonstratedcultures obtained by subculturing limbospheres, the
highly proliferating f-LSCs showed increased positivity that the decrease in SSEA4 expression overtime was not
caused by cell death (<2.7%, data not shown).for SSEA4 (90.8 ± 7.6%). SSEA4+ f-LSCs coexpressed
the stem cell markers octamer binding transcription fac-
Directed Differentiation of f-LSCs Cells Towardstor [OCT4; double positive (DP): 92.7 ± 4.3%], sex
the Pancreatic Endocrine Phenotypedetermining region Y box 2 (SOX2; DP: 91.9 ± 5.6%),
NANOG (DP: 98.6 ± 1.3%), c-KIT (DP: 93.6 ± 3.3%), We developed a four-step protocol for differentiation
of f-LSCs into pancreatic endocrine cells through aTRA 1-60 (DP: 95.3 ± 4.1%), TRA 1-81 (DP: 95.0 ±
3.1%), THY-1 (DP: 94.5 ± 3.6%), CD105 (DP: 88.3 ± series of intermediates mimicking in vivo pancreatic
organogenesis. Stepwise, we added factors and supple-2.3%), and the limbal marker ATP-binding cassette sub-
family G member 2 (ABCG2; DP: 94.9 ± 4.8%) (4,9). ments known to direct/support pancreatic differentiation
of embryonic stem cells, such as activin A, bFGF, B27,CD133 was weakly expressed or absent (DP: 5.2 ± 2.9%
only in 4 out of 14 primary cultures; data not shown). f- N2, nicotinamide, and exendin-4 (protocol A, Fig. 3A)
(6,20,24,34). The substitution or addition of other mole-LSCS were also negative for CD34, CD45, human lym-
phocyte antigen (HLA)-DR, and the LESC marker cules, such as FGF10 and retinoic acid (RA), was also
investigated based on previous evidence reporting∆Np63 (Fig. 1D) (10). To exclude that the absence of
these markers in f-LSCs was due to experimental arti- improvement in endoderm formation and increase in
insulin content of ESC-derived surrogate β-cells (proto-facts, freshly isolated PBMCs and HeLa cells were used
as positive controls (data not shown). The expression of col B, Fig. 3B) (7,21).
At stage 1 and 2 (days 1–7), we focused on generat-all stem cell markers was unaffected by long-term cul-
ture and was assessed up to 92 population doublings ing definitive endoderm (DE) and posterior foregut (PF).
During stage 1 we used high concentrations of activin(data not shown). The “stem-like” profile of f-LSCs was
confirmed by qRT-PCR (Fig. 1E), which also showed A in serum-free media, while in stage 2 activin A was
removed, and either bFGF (protocol A) or FGF10 (pro-expression of Kruppel-like factor 4 (KLF-4), c-MYC,
and CD73. Table S2 (supplemental material) summa- tocol B) was added in the context of low FBS supple-
mentation. Soon upon activin A removal, a consistentrizes the markers that identify f-LSCs.
f-LSCs were also evaluated for the ability to divide percentage of f-LSCs transitioned to DE as indicated by
the remarkable upregulation of SOX17 and Forkheadasymmetrically, a key stem cell feature (Fig. 2). Prior to
assay, cells were sorted for SSEA4 to ensure a purified Box-A2 (FOXA2) mRNAs (Fig. 3C) and the subsequent
protein detection by immunofluorescence (Fig. 4A, B).SSEA4+ f-LSC population (Fig. 2A). Cells were then
labeled with fluorescent dye CFSE in order to track cell Of note, differentiating cells progressively aggregated
into spherical cell clusters resembling human islets. Atdivision (Fig. 2B). Cells were either cultured in expan-
sion medium (supporting maintenance of the pluripotent the beginning of stage 2 we also observed significant
upregulation of pancreatic and duodenal homeobox 1phenotype) or in a basal medium (and thus allowing
asymmetric division). Immunofluorescence analysis per- (PDX1), which is indicative of PF formation (Fig. 3C)
(26). PDX1+ cells could be detected in both the formingformed at 24, 48, and 72 h in basal medium showed
increasing number of CFSE+/SSEA4− cells, while sev- islet-like clusters and in the surrounding monolayer
(89.3 ± 4.1% at the end of stage 2). PDX1+ cells coex-eral mitotic cells showed polarized SSEA4 distribution
(Fig. 2C and D, arrows). In addition, flow cytometry pressed NK6 homeobox 1 (NKX6.1), which is character-
istic of pancreatic epithelium (Fig. 4C) (26). Neurogeninanalysis after 72 h showed that the number of SSEA4+
cells remained unchanged while the total cell population 3 (NGN3) expression, as expected, was transient and
peaked at the end of stage 2, along with the increase ofincreased, thus suggesting asymmetric division. By con-
trast, at 72 h cells cultured in expansion medium main- ISL LIM homeobox 1 (ISL1), paired box gene 4 (PAX4),
NKX6.1, and neurogenic differentiation 1 (NEUROD1),tained SSEA4 expression as their number progressively
increased, indicating cells divided symmetrically during all transcription factors controlling endocrine cell differ-
entiation (Fig. 3C) (15,16). Indeed, low levels of theseproliferation (data not shown). Asymmetrical division of
SSEA4+ cells was further evaluated indirectly over a 15- pancreatic genes were already detected at the end of
stage 1, thus suggesting that a high dose of activin Aday period by culturing f-LSCs in the same conditions
described above (Fig. 2E). SSEA4 expression detected alone was able to initiate transcription of DE and PF
markers. Nevertheless, if activin A was not removedby flow cytometry gradually decreased from 98% on
day 0 (after sorting) to 58% on day 8, and maintained a and either bFGF or FGF10 was added, generation of
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Figure 2. Self-renewal ability of f-LSCs. (A) f-LSCs were sorted for stage-specific embryonic antigen 4 (SSEA4) prior to assay,
in order to ensure a purified population. Left: before sorting; right: after sorting. Purple peak: negative control. Red peak: SSEA4.
(B) SSEA4+ cells (red) were then labeled with fluorescent dye carboxyfluorescein succinimidyl ester (CFSE; green) in order to
track cell division. The dye–protein adducts that form in labeled cells were retained by daughter cells after either cell division or
cell fusion, and CFSE was not transferred to adjacent cells. Note that all cells were positive for SSEA4 and CFSE after sorting.
(C) Cells were cultured in a basic medium not containing basic fibroblast growth factor (bFGF). Immunofluorescence analyses
performed at 24, 48, and 72 h show increasing number of CFSE+/SSEA4− cells, suggesting they divided asymmetrically. Arrows
indicate polarized SSEA4 expression in premitotic or mitotic cells. Scale bar: 100 µm. (D) Higher magnification of (C). Scale bar:
100 µm. (E) Asymmetrical division of SSEA4+ cells evaluated indirectly over a 15-day period. SSEA4 expression detected by flow
cytometry decreased from 98% on day 0 (after sorting) to 58% on day 8, and maintained a steady state up to the last day of the
assay. Instead, cell proliferation detected by bromodeoxyuridine (BrdU) continued for the entire culture period, thus suggesting that
SSEA4+ cells divide asymmetrically. Data are representative of five independent experiments.
hormone-producing cells in the subsequent stages did ghrelin (GHRL) transcripts (Fig. 3C). However, no hor-
mone-producing cells were found by immunofluores-not take place or was significantly reduced (data not
shown). By the end of stage 2, NGN3 showed a nuclear cence at this stage (Fig. 4E). In addition, by day 8 the
expression of stem cell markers was already negligiblelocalization in a substantial number of PDX1+ cells, con-
sistent with endocrine determination (Fig. 4D). At the (supplemental information in Fig. 1).
At stage 3 (days 8–12), bFGF was removed and B27,end of stage 2, we also noted upregulation of glucose
transporter 2 (GLUT2) and glucokinase (GCK), along N2, and nicotinamide were added to further improve the
yield and maturation of pancreatic endocrine precursorswith the appearance of insulin (INS), glucagon (GCG),
somatostatin (SST), pancreatic polypeptide (PPY), and (protocol A). Alternatively, FGF10 was maintained for
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Figure 3. (A, B) Four-step protocols for differentiation of f-LSCs into pancreatic hormone-expressing cells. Media, growth factors,
supplements, and range of duration for each stage are indicated. (A) Protocol A. (B) Protocol B. Stage 1 is the same in the two
protocols, and leads to formation of definitive endoderm, which is a crucial step for the subsequent differentiation towards the
pancreatic phenotype. DE, definitive endoderm; PF, posterior foregut; PE, pancreatic endoderm; ISL, hormone-expressing islet
cells. (C) Expression of pancreatic/β-cell markers during differentiation. f-LSCs express pancreatic, islet, and β-cell markers in
temporal succession, according to stages of differentiation. From stage 2 black bars indicate protocol A, gray bars indicate protocol
B, and striped bars indicate expression in 500 handpicked human islets. Bars represent gene expression at the end of each stage.
Quantification for each gene of interest is performed in relation to a standard curve (arbitrary units) and gene expression is
normalized for the housekeeping gene β-actin. Values are shown as mean ± SE of nine experiments for protocol A and three
experiments for protocol B. See also Figure S1B (supplemental material) for decrease of stem cell markers during differentiation.
3–4 more days, in the presence of B27 and RA (protocol 3C). Differentiating cells showed a perinuclear or polar-
ized localization of proinsulin (C-PEP/PROINS), consis-B). At the end of this stage, by about 12 days of differ-
entiation, we observed consistent upregulation of INS tent with immature phenotype (Fig. 4F). By contrast, in
later-stage cells the hormone filled and delineated theand v-maf musculoaponeurotic fibrosarcoma oncogene
homolog A (avian) (MAFA) mRNAs. Transcripts for cytoplasm (Fig. 4G). The absence of NGN3 staining at
this stage (data not shown), along with the very low levelsGCG, SST, GHRL, and PPY were also detectable (Fig.
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of NGN3 mRNA, indicated that the majority of cells halo surrounding a less dense core, a morphology that is
characteristic of insulin-containing vesicles (Fig. 7C).already underwent endocrine determination.
At stage 4 (days 13–15), the islet-like clusters
Insulin Content and Insulin Releaseincreased in number and size (Fig. 5A). In addition, cells
From Differentiated f-LSCsdouble stained for C-PEP/PROINS and INS, suggesting
further maturation. Interestingly, in bigger islet-like To confirm de novo synthesis and release of insulin,
we investigated the ability to secrete C-peptide inclusters staining for proinsulin was more marked in the
cells of the inner core, while outer cells stained strongly response to secretory stimuli (Fig. 7D) (29). Stimulation
with 20 mM glucose, 100 µM of the secretagogue tolbu-for mature insulin (Fig. 5B; video S1 in supplemental
material). GLUT2, which is part of the “glucose sensor” tamide, or direct depolarization with 30 mM potassium
chloride (KCl) resulted in a robust C-peptide secretionalong with GCK, showed a similar localization (Fig.
5C). By contrast, smaller islet-like cluster had a more in the culture medium during 2-h static incubation. All
three stimuli showed rapid kinetics with a peak of secre-homogeneous C-PEP/PROINS and INS distribution
(Fig. 5D, E; video S2 in supplemental material). In some tion within 5 min. A biphasic profile was observed after
glucose stimulation with a second phase of secretionislet-like clusters a few cells of the inner core also
expressed GCG (Fig. 5E). Rare single SST+ and GCG+ around 10 min from the beginning of incubation. Fold
stimulation of C-peptide release over the respectivecells were randomly found in the monolayer (Fig. 5F,
G). A confocal image of an islet-like cluster is shown in basal condition during 1-h static incubation resulted in
4- to 6-fold increase after glucose stimulation, 5- to 11-Figure 6A. At this stage, almost all C-PEP/PROINS+
cells also expressed MAFA and PDX1 (Fig. 6B). West- fold increase after tolbutamide, and 8- to 12-fold after
KCl (Fig. 7E). C-peptide secretion after 1-h static incu-ern blot analysis expression confirmed protein expres-
sion of GLUT2, PDX1, and GCK (Fig. 6C). bation was 15- to 28-fold less than that observed for
adult human islets incubated in the same conditions (Fig.No substantial differences were observed between
protocol A and protocol B in inducing the expression 7F). To accurately evaluate the ability to process insulin,
we measured both C-peptide and proinsulin by ELISAof the majority of islet and β-cell-specific transcription
factors. However, concerning hormone production, pro- on cell lysates. Total insulin content in differentiated f-
LSCs was about 160-fold lower than in adult humantocol A was more efficient in inducing formation of
islet-like clusters. Minor differences were observed in islets. However, the average proportion of total insulin
content attributable to C-peptide in differentiated f-LSCsthe differentiation outcome among the primary cell cul-
tures used. was comparable to that of human islets (98%; range
97–99.5%) (Fig. 7G). Morphology of an islet-like clus-
ter after 1-h static incubation with 20 mM glucose isQuantification of Differentiated f-LSCs
shown in Figure 7H.To quantify hormone-expressing cells, we performed
flow cytometry after completing differentiation at stage DISCUSSION
4 (Fig. 7A). Analysis showed an average of 72.1 ± 5.3% Cultured human limbal epithelial stem cells havepositive cells for C-PEP/PROINS, with higher rates been successfully used for corneal reconstruction. How-
obtained with protocol A. GCG+ and SST+ cells were
ever, human ocular stem cell research has been mainly10.6 ± 2.4% and 8.2 ± 2.6%, respectively. qRT-PCR anal- focused on the tissue-specific differentiation that may beysis showed higher INS expression in the islet-like clus-
of clinical significance in the context of eye diseases.
ters in comparison to monolayer cells (data not shown). Here we show how the limbus hosts a fibroblast-like
stem cell population that could be harvested for clinical
Differentiated f-LSCs Possess Secretory Granules use in type 1 diabetes. The phenotypic characterization
of f-LSCs has been variably described (11,12,28). WeTo confirm the degree of maturation of hormone-
expressing cells, we investigated whether they formed have identified a core set of attributes that uniquely
characterizes f-LSCs, such as the expression of the well-secretory granules. Confocal microscopy of C-PEP- and
INS-stained cells showed a granulated pattern of the established stem cell surface antigens SSEA4, TRA 1-
60, TRA 1-81, THY1, c-KIT, CD105, CD73, and thecytoplasm, consistent with the existence of secretory
granules (Fig. 6B) (6). Several INS+ cells coexpressed limbal stem cell marker ABCG2. f-LSCs also expressed
several nuclear transcription factors, such as OCT4,the vesicle protein synaptophysin (SYP), and flow cytom-
etry analysis indicated an average percentage of coex- NANOG, SOX2, KLF-4, and c-MYC, which are
involved in self-renewal and maintenance of pluripo-pression of 69.0 ± 3.9% (Fig. 7B). Electron microscopy
also revealed secretory granules in the cytoplasm and tency of both embryonic and adult stem cells (40,44).
The LESC marker ∆Np63 was negative, confirming thenext to the cell membrane. Some of them showed a clear
